+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cephalosporins"

Beta-Lactamase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-Lactamase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
UAE Antibiotics Market, By Region, By Competition Forecast & Opportunities, 2018-2028F - Product Thumbnail Image

UAE Antibiotics Market, By Region, By Competition Forecast & Opportunities, 2018-2028F

  • Report
  • November 2023
  • 79 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
From
From
From
From
From
Cephalosporin Markets in China - Product Thumbnail Image

Cephalosporin Markets in China

  • Report
  • October 2024
  • 270 Pages
  • China
From
Loading Indicator

Cephalosporins are a class of antibiotics used to treat a wide range of bacterial infections. They are derived from the fungus Cephalosporium and are closely related to penicillin. Cephalosporins are divided into four generations, each generation having a broader spectrum of activity than the previous one. They are used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. Cephalosporins are also used to treat some sexually transmitted diseases, such as gonorrhea. Cephalosporins are widely used in both human and veterinary medicine. They are available in a variety of formulations, including tablets, capsules, suspensions, and injections. Cephalosporins are generally well tolerated, with few side effects. Some companies in the Cephalosporins market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and AstraZeneca. Show Less Read more